Stay informed with the latest litigation news. Explore now

IP Verse

Stada Arzneimittel competitive analysis

Latest publications and patents of Stada Arzneimittel New

Explore the latest publications and patents granted to Stada Arzneimittel, showcasing their recent innovations and technological advancements.

Last updated on: Sep 8, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Stada Arzneimittel
EP3324936	Sep 28, 2022	Method For Producing A Bortezomib Ester Solution	Granted And Under Opposition
EP3324937	Aug 17, 2022	Ready-To-Use Bortezomib Solution	Granted And Under Opposition
EP2233127	May 27, 2020	Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations	Granted And Under Opposition
EP1591105	May 27, 2020	Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations	Revoked

Latest oppositions filed by Stada Arzneimittel

Explore patent oppositions filed by Stada Arzneimittel against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP4218732	Tablets Comprising Eltrombopag Olamine	NOVARTIS	Aug 5, 2025
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 1, 2025
EP2662094	Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors	ONYX THERAPEUTICS	Jan 17, 2025
EP3781132	Apixaban Formulations	BRISTOL MYERS SQUIBB	Dec 19, 2024
EP3628319	Methods Of Treating Hepatic Encephalopathy Using Rifaximin	SALIX PHARMACEUTICALS	Nov 13, 2024
EP2395968	Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient	BOEHRINGER INGELHEIM	Oct 17, 2024
EP3478286	Methods Of Treating Ovarian Cancer	TESARO	Oct 2, 2024
EP3494972	Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection	VIIV HEALTHCARE	Sep 11, 2024
EP3744326	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Sep 5, 2024
EP3581183	Tumor-Treating Pharmaceutical Composition	EISAI R&D MANAGEMENT	Aug 29, 2024

Latest patents of Stada Arzneimittel opposed by its competitors

Explore Stada Arzneimittel's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3324936	Sep 28, 2022	Method For Producing A Bortezomib Ester Solution	6
EP3324937	Aug 17, 2022	Ready-To-Use Bortezomib Solution	7
EP1591105	May 27, 2020	Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations	6
EP2233127	May 27, 2020	Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations	9

Latest PTAB cases involving Stada Arzneimittel New

Discover the latest PTAB cases involving Stada Arzneimittel, highlighting their recent legal challenges and patent disputes.

Top competitors of Stada Arzneimittel

Top competitors of Stada Arzneimittel based on patent oppositions.

NOVARTIS

MUNDIPHARMA

PFIZER